5- Hydroxytryptophan formation

Mitoma, C., Weissbach, H. and Udenfriend, S., 5-Hydroxytryptophan formation and tryptophan metabolism in Chromobacterium violaceum. Arch. Biochem. Biophys. 63, 122 (1956). 

In contrast, substrates having other struetural types of side ehain at the 3 position dimerize under aeidie eonditions, and never produee the 5-substituted produets. These faets seem to support the 1-Hydroxyindole Hypotheses, whieh elaim the formation of serotonin from 1-hydroxytryptophan and/or -tryptamine in the aeidie eompartment within eukaryotie eells. 

Serotonergic neurons contain the enzyme L-tryptophan-5-monooxygenase (EC 1.14.16.4), more commonly termed tryptophan hydroxylase, which converts tryptophan to 5-hydroxytryptophan (5-HTP) (Fig. 13-5). Tryptophan hydroxylase contains 444 amino acids, corresponding to a molecular weight of about 51 Da. This enzyme is synthesized in serotonergic cell bodies of the raphe nuclei and is found only in cells that synthesize 5-HT. Therefore its distribution in brain is similar to that of 5-HT itself. The Km of tryptophan hydroxylase for tryptophan is approximately 30-60 pmol/1, a concentration comparable to that of tryptophan in brain. If the concentration of tryptophan in serotonergic neurons is assumed to be comparable to that in whole brain, the enzyme would not be saturated with substrate, and the formation of 5-HT in brain would be expected to rise as the brain concentration of tryptophan increases. This has been found to occur in response to raising the dietary intake of tryptophan specifically. 

Dietary tryptophan is the source of the formation of serotonin. Enzymes and cofactors necessary for serotonin synthesis are present in both the enterochromaf-lin cells of the gastrointestinal tract and neurons in the brain. Tryptophan is initially hydroxylated to form 5-hydroxytryptophan. Decarboxylation of the latter compound results in the formation of serotonin (Fig. 24.2). 

Whilst the term biogenic amine strictly encompasses all amines of biological origin, for the purpose of this article it will be employed to refer to the catecholamine (dopamine, noradrenaline) and serotonin group of neurotransmitters. These neurotransmitters are generated from the amino acid precursors tyrosine and tryptophan, respectively, via the action of the tetrahydrobiopterin (BH4)-dependent tyrosine and tryptophan hydroxylases. Hydroxylation of the amino acid substrates leads to formation of 3,4-dihydroxy-l-phenylalanine ( -dopa) and 5-hydroxytryptophan, which are then decarboxylated via the pyridoxalphosphate-dependent aromatic amino acid decarboxylase (AADC) to yield dopamine and serotonin [4]. In noradrenergic neurones, dopamine is further metabolised to noradrenaline through the action of dopamine-jS-hydroxylase [1]. 

The hereditary absence of phenylalanine hydroxylase, which is found principally in the liver, is the cause of the biochemical defect phenylketonuria (Chapter 25, Section B).430 4308 Especially important in the metabolism of the brain are tyrosine hydroxylase, which converts tyrosine to 3,4-dihydroxyphenylalanine, the rate-limiting step in biosynthesis of the catecholamines (Chapter 25), and tryptophan hydroxylase, which catalyzes formation of 5-hydroxytryptophan, the first step in synthesis of the neurotransmitter 5-hydroxytryptamine (Chapter 25). All three of the pterin-dependent hydroxylases are under complex regulatory control.431 432 For example, tyrosine hydroxylase is acted on by at least four kinases with phosphorylation occurring at several sites.431 433 4338 The kinases are responsive to nerve growth factor and epidermal growth factor,434 cAMP,435 Ca2+ + calmodulin, and Ca2+ + phospholipid (protein kinase C).436 The hydroxylase is inhibited by its endproducts, the catecholamines,435 and its activity is also affected by the availability of tetrahydrobiopterin.436... 

Aromatic L-amino acid decarboxylase catalyzes the decarboxylation of l-5-hydroxytryptophan (l-5-HTP) to serotonin (5-HT). In the assay, l-5-HTP was used as the substrate and the formation of 5-HT was measured. 

Tryptophan appears to be converted to a larger number of metabolites than any of the other amino acids. The degradation of tryptophan in animals occurs mainly in two pathways, I and II (Figure 4.1). The first major pathway (I), initiated by the action of tryptophan dioxygenase, involves oxidation of tryptophan to N - fc > r my I ky n urenine and the formation of a series of intermediates and byproducts, most of which appear in varying amounts in the urine, the sum of which accounts for the total metabolism of tryptophan, approximately. The second pathway (II) involves hydroxylation of tryptophan to 5-hydroxytryptophan and decarboxylation of this compound to 5-hydroxytryptamine (serotonin), a potent vasoconstrictor found particularly in the brain, intestinal tissues, blood platelets, and mast cells. A small percentage (3%) of dietary tryptophan is metabolized via the pathway (III) to indoleacetic acid. Other minor pathways also exist in animal tissues. 

The hydroxylation of tryptophan produces 5-hydroxytryptophan, which can then be decarboxylated, catalyzed by tryptophan decarboxylase, a PALP-requiring enzyme, to 5-hydroxy tryptamine, also known as serotonin. Serotonin is an important compound in normal brain function and tranquility. Therefore, any disturbance of tryptophan metabolism via this pathway can lead to mental disturbances. Serotonin can be destroyed by the enzyme monoamine oxidase (a flavo protein), which catalyzes the formation of ammonia and 5-hydroxyindole acetaldehyde in an irreversible reaction. The aldehyde is rapidly oxidized enzymatically, utilizing NAD+ to form 5-hydroxy indoleacetate, which is then usually excreted. The formation and turnover of serotonin can be estimated by 5-hydroxy indoleacetate output in the urine. 

The other physiologically important monoamine is 5-hydroxytryptamine (serotonin or 5-HT). It is formed from tryptophan via 5-hydroxytryptophan (5-HTP) Figure 5.2). The nature and properties of tryptophan-5-hydroxy-lase is still obscure, though the hydroxylation of tryptophan in vivo has been demonstrated. There is no clear evidence that this conversion occurs in brain tissue. The decarboxylation of 5-HTP, however, takes place in brain and the decarboxylating enzyme is found in all cerebral areas which contain 5-hydroxytryptamine. 5-HTP decarboxylase is closely related to, if not identical with, DOPA decarboxylase - and agents which inhibit dopan ine formation similarly inhibit the production of 5-hydroxytryptamine. There... 

Brain cells take up tryptophan, which is then converted to 5-hydroxytryptophan by tryptophan hydroxylase, an enzyme whose activity is similar to that of phenylalanine hydroxylase. Aromatic amino acid decarboxylase then catalyzes the formation of the potent neurotransmitter 5-hydroxytryptamine, also called serotonin. In the blood, tryptophan is bound to serum albumin, with an affinity such that about 10% of the tryptophan is freely diffusable. The rate of tryptophan uptake by brain cells depends on the concentration of free tryptophan. In these cells, tryptophan concentration is normally well below that of the Km for tryptophan hydroxylase. Aspirin and other drugs displace tryptophan from albumin, thereby increasing the concentration of free tryptophan. 

In mammals, conversion of L-tryptophan to 5-hydroxy-tryptophan (7) is the first step in the formation of the biologically active amine serotonin or 5-hydroxytryptamine (Fig. 13.16) (Udenfriend et al., 1956). 5-Hydroxytryptophan has been isolated from the legume Mucuna pruriens as well as from cotton and bananas (Rosenthal, 1982). 

Acetylcholine is formed from choline (which is also an important constituent of phospholipids) and acetyl CoA under the catalytic influence of choline acetyl-ase. It is hydrolised by acetylcholinesterase or choline esterase. Two important steps in the formation of noradrenaline from tyr dopa decarboxylase and dopamine hydroxylase. Adrenaline is formed from noradrenaline by phenyl ethanolamine A -methyltransferase. Both noradrenaline and adrenaline are metabolised by catechol 0-methyl transferase or monoamine oxidase. Some later steps in their metabolism involve aldehyde dehydrogenase and alcohol dehydrogenase (aldehyde reductase), After hydroxylation to its 5-hydroxy derivative, tryptophan is converted by 5-hydroxytryptophan decarboxylase to 5-hydroxytryptamine (serotonin). The major routes of serotonin metabolism involve either monoamine oxidase or hydroxyindole 0-methyltransferase. Histamine is synthesised from histidine by histidine decarboxylase, and is metabolised by either diamine oxidase or histamine Af-methyltransferase. Gamma aminobutyric acid is formed by glutamate decarboxylase and metabolised by... 

Pharmacological evidence was obtained several years ago that indicated that tryptophan is decarboxylated to tryptamine by both animal and bacterial enzymes. More recent studies have failed to detect this reaction, but instead have shown decarboxylation to occur only after oxidation of the indole nucleus to yield 5-hydroxytryptophan. Decarboxylation of 5-hydroxytryptophan produces 5-hydroxytryptamine, serotonin, which has important, though incompletely defined functions in animal physiology. In some animal livers there is an enzyme that decarboxylates cysteic acid to taurine. Glutamic decarboxylase has been found in animal brain, where it is responsible for the formation of 7-aminobutyric acid. This product has been implicated in nervous function as an inhibitor of synaptic transmission. ... 

Also, vitamin C is required for the conversion of tryptophan to 5-hydroxytryptophan, the first step in the formation of the serotonin, a compound that raises blood pressure through vasoconstrictor action. 

Significance of g-Hydroxytryptophan iOxinddyUdanine). When the oxidation of tryptophan was assumed to act through a peroxide, it was speculated that this converted the trsrptophan to an unknown intermediate, which was converted by a second component of the enzyme to formylkynurenine with simultaneous formation of peroxide, which in turn accelerated the oxidation to form more of the unknown intermediate. 

The formation of diastereomers of 4-[4 -(6-hydroxyquinolyl)]-5-hydroxytryptophan (27) upon oxidation of 5-HTPP is a rather unusual reaction. It seems unlikely that these diastereomers would be formed from different intermediates than are the 4,4 -dimers (14) or tryptophan-4,5-dione (17). The structures of the indole-quinoline dimers suggest that the C(4)-position of one 5-HTPP residue must attack the C(3)-position of another residue. There are several ways that a coupling of 5-HTPP residues would occur. It was originally proposed that quinone imine 15 is... 

---